Skip to main content

ABL kinase inhibition sensitizes SCLC to dysregulation of metabolic pathways leading to cell death

Fellowship Grant
Duke Scholars

Administered By

Pharmacology & Cancer Biology

Awarded By

National Institutes of Health

Start Date

June 1, 2024

End Date

May 31, 2026
 

Administered By

Pharmacology & Cancer Biology

Awarded By

National Institutes of Health

Start Date

June 1, 2024

End Date

May 31, 2026